AviadoBio

During this time of gratitude, we'd like to give thanks to #TeamAviadoBio, our patient communities, and our advocacy partners. Your strength, dedication, and support inspire us every day as we work to develop potential treatments for those facing devastating neurodegenerative diseases.

We’re thrilled to be attending the OBN (UK) Ltd Awards tonight as finalists for the Best Emerging #Biotech Company category. Here’s to an exciting evening of celebrating innovation in #LifeSciences and the future of biotech! #OBNAwards #LifeSciencesAwards #CelebrateInnovation

Tonight, we're attending the #EuropeanLifestarAwards - Celebrating Life Science Leaders! Our company CEO, Lisa Deschamps is among the talented nominees as a finalist for the “Women-Led Business Leader of the Year” award. We are incredibly proud of her nomination and look forward to celebrating with the other finalists. #LifestarsAwards #LLSW2024

We're looking forward to participating in London Life Sciences Week filled with global #biotech collaboration, dealmaking, and celebrating London #LifeSciences.     Learn more: https://lnkd.in/ekymUxmJ     #LondonLifeSciencesWeek #LLSW2024 #LifeSciences #LondonLifeSciences 

Thank you OUTbio UK for a great career discussion and networking event last night. We were honored to be your event partner. Informative discussions and great networking!    Find out more about OUTbio UK here  www.outbio.uk 

National STEM Day takes place on the 8th of November each year and celebrates and promotes the fields of science, technology, engineering, and mathematics.     This year we are shining a light on our intern program and the impact it can have.      Nicholas Manners-Bell shares his experiences during his time working with the AviadoBio team.      Q: How did you learn about AviadoBio, and why did you decide to join as an intern/fellow?     As a student seeking work experience, I did some research on companies that had offices in London which were involved in gene therapies and came across AviadoBio. After researching their primary drug, AVB-101, I found it particularly interesting and decided to enquire whether they would be open to having me as a summer intern within an administrative role. I hoped to be able to learn what went on inside a start-up and to make good industry contacts.     Q: Briefly describe the work you were involved with during your time at AvaidoBio. Which parts of the role did you enjoy most, and why? I held the role of Project Leadership Intern, working under the Director of Program Management. My daily tasks involved attending meetings for various projects and assisting with basic administrative duties. Additionally, I supported the regulatory team in finalizing an IND submission to the FDA and collaborated with the clinical team alongside the CRO. This exposure to different departments provided me with a holistic understanding of how a start-up functions something that cannot be fully grasped through University alone.     Q: How has the summer internship/fellowship program helped to crystallize your vision for your post-university career?    Before starting the internship, I knew I wanted to work in drug development, yet I was eager to move on from university and start building my career. However, I didn’t know where to start. During my time at AviadoBio, through exposure to the many internal departments, I discovered my interest lay in clinical trials, which led me to pursue a different type of career after I had completed the internship. This ultimately brought me to my current position as a Clinical Trials Assistant at the Oxford Vaccine Group, a role that I didn’t even know existed before AviadoBio. Because of this, I am incredibly grateful for my time at AviadoBio, which gave me both a foot in the door and helped clarify the direction I wanted to take my career. The attached photo shows me networking at the Oxford Uni fresher’s fair.    AviadoBio has a yearly Summer Intern program. Those roles will be listed on our website www.aviadobio.com/careers in 2025.   #STEM #NationalSTEMDay

Tomorrow, our Director of Discovery, Catia Andreassi, will be giving a Keynote Address during Track 2: Preclinical CGT Assessments: Research & Development at this year’s #Cell2024 meeting! Learn more about her presentation: https://shorturl.at/jxLlu      #GeneTherapy  

This Family Caregivers Month, we honor individuals like Katie Brandt.     Watch as she shares her heartfelt experiences caring for a loved one with FTD—especially during the holiday season and learn more about how to navigate this sensitive time.     #FrontotemporalDementia

Are you attending the European Society of Gene and Cell Therapy Annual Congress? Let’s connect! Our team will be on-site presenting 7 different posters and is looking forward to exchanging information about the latest updates in #GeneTherapy! Learn more: https://lnkd.in/efye-f8c #ESGCT2024

We’re thrilled to announce with Astellas Pharma, an exclusive option and license agreement for AVB-101, an investigational, AAV-based #GeneTherapy in Phase 1/2 development for patients with #FrontotemporalDementia with progranulin mutations (FTD-GRN). Learn more: https://lnkd.in/e3CrzXPN #biotech